Clinical trial

Enhanced Quitline Intervention in Smoking Cessation for Patients With Non-Metastatic Lung Cancer

NCT01457469

Drugs and interventions used in this trial

8 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

OTHER · Unmapped registry intervention questionnaire administration Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention quality-of-life assessment Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention counseling intervention Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention internet-based intervention Find medicine records · Find other trials using this name

BEHAVIORAL · Unmapped registry intervention telephone-based intervention Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention educational intervention Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention nicotine replacement therapy Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention educational intervention Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Enhanced Quitline Intervention in Smoking Cessation for Patients With Non-Metastatic Lung Cancer

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-01-01

PhasePHASE1

Conditions

Limited Stage Small Cell Lung Cancerunresolved

Recurrent Small Cell Lung Cancerunresolved

Stage IA Non-small Cell Lung Cancerunresolved

Stage IB Non-small Cell Lung Cancerunresolved

Stage IIA Non-small Cell Lung Cancerunresolved

Stage IIB Non-small Cell Lung Cancerunresolved

Stage IIIA Non-small Cell Lung Cancerunresolved

Stage IIIB Non-small Cell Lung Cancerunresolved

Tobacco Use Disorderunresolved

Interventions

questionnaire administrationOTHER

quality-of-life assessmentPROCEDURE

counseling interventionOTHER

internet-based interventionOTHER

telephone-based interventionBEHAVIORAL

educational interventionOTHER

nicotine replacement therapyDRUG

educational interventionOTHER

Sponsors & collaborators

Wake Forest University Health Scienceslead sponsor

National Cancer Institute (NCI)collaborator

Mapped research locations

Winston-SalemNorth Carolina, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01457469 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.